China's Sinopharm says data 'better than expected' from it's COVID vaccine trial1 min read . Updated: 11 Nov 2020, 06:46 PM IST
- Sinopharm's unit CNBG has moved two vaccine candidates into Phase 3 clinical trials outside China in multiple countries including the UAE, Bahrain and Egypt
- It did not offer details on the better-than-expected data, or specify which vaccine candidate the data are generated from
China National Pharmaceutical Group (Sinopharm) said on Wednesday the data from large-scale, late-stage clinical trials for its unit's COVID-19 vaccine are "better than expected".
Select your Category